Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

March 01, 2012 (Vol. 32, No. 5)

Optimizing LC/MS for Drug Bioanalysis

  • Bioanalysis of drugs in development is shifting toward high-sensitivity and high-throughput methodologies based on LC/MS platforms capable of drug and metabolite identification and quantification, with the ability to detect low-volume analytes and to discriminate between closely related molecules in complex biological samples. At the upcoming “Pittcon” conference, several presentations ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.